• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Role of hypoxia inducible factor-1α in renal cancer

Research Project

Project/Area Number 14571525
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Urology
Research InstitutionNippon Medical School

Principal Investigator

KONDO Yukihiro  Nippon Medical School, Dept. of Urology, Associate professor, 医学部, 助教授 (80215467)

Project Period (FY) 2002 – 2003
Project Status Completed (Fiscal Year 2003)
Budget Amount *help
¥3,500,000 (Direct Cost: ¥3,500,000)
Fiscal Year 2003: ¥1,300,000 (Direct Cost: ¥1,300,000)
Fiscal Year 2002: ¥2,200,000 (Direct Cost: ¥2,200,000)
Keywordsrenal cancer / hypoxia / HIF-1α / angiogenesis / proliferation / 低酸素応答性転写因子
Research Abstract

Hypoxia-inducible factor-1α, HIF-1α, is a transcriptional factor that regulates genes involved in the response to hypoxia. To clarify its roles in tumour growth and progression, we established HIF-1α-overexpressing renal cell carcinoma VMRC cells (VMRC-HIF1α cells) and bladder cancer EJ cells (EJ-HIF1α cells) and compared their characteristics with VMRC-neo and EJ-neo control cells. In vitro studies showed that overexpression of HIF-1α in both VMRC and EJ cells relieves the contact inhibition of cell proliferation and renders these cells resistant to hypoxic stress. We further examined in vivo tumourigenicity in nude mice. All four types of cancer cells (VMRC-neo cells, VMRC-HIF1α cells, EJ-neo cells, and EJ-HIF1α cells) formed tumours in nude mice, and the size of VMRC-HIF1α cell-derived xenografts was much larger than that of VMRC-neo cells. Although HIF-1α overexpression did not affect the size of EJ cell-derived xenografts, histological examination showed that there was only a small area of necrosis in the EJ-HIF1α cell-derived xenografts whereas a large area of central necrosis was observed in the EJ-neo cell-dereived xenografts. It was also found that HIF-1α overexpression increased intratumoural microvessel density in the xenografts. These results suggest that HIF-1α may play important roles in bladder and renal cancer angiogenesis, growth and progression.

Report

(3 results)
  • 2003 Annual Research Report   Final Research Report Summary
  • 2002 Annual Research Report
  • Research Products

    (13 results)

All Other

All Publications (13 results)

  • [Publications] Kondo, Y., Hamada, J., et al.: "Overexpression of hypoxia-inducible factor-1α in renal and bladder cancer cells increases tumorigenic potency"J.Urol..

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Takahashi, R., Kobayashi, C., Kondo, Y., et al.: "Subcellular localization and regulation of hypoxia-inducible factor-2α in vascular endothelial cells"Biochem.Biophys.Res.Commun.. 317. 84-91 (2004)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Maynard, MA., Qi, H., Lee, EHL., Kondo, Y., et al.: "Multiple splice variants of the human HIF-3α locus are targets of the VHL E3 ubiquitin ligase complex"J.Biol.Chem.. 278. 11032-11040 (2003)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Kondo, Y., Himeno, S., et al.: "Citrate enhances the protective effect of orally administered bismuth subnitrate against the nephrotoxicity of CDDP"Cancer Chemother Pharmacol. 53. 33-38 (2004)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Kondo, Y., et al.: "Optimal administration schedule of cisplatin for bladder tumor, in relation to tissue metallothionein levels"J.Urol.. 170. 2467-2470 (2003)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Kondo, Y., Hamada, J., et al.: "Overexpression of hypoxia-inducible factor-1a in renal and bladder cancer cells increases tumorigenic potency"J.Urol..

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Takahashi, R., Kobayashi, C., Kondo, Y., et al.: "Subcellular localization and regulation of hypoxia-inducible factor-2a in vascular endothelial cells"Biochem.Biophys.Res.Commun.. 317. 84-91 (2004)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Yukihiro Kondo, Seiichiro Himeno, Kenji Yamagata, Akira Naganuma, Masahiko Satoh, Nobumasa Imura, Taiji Nishimura: "Optimal Administration Schedule Of Cisplatin For Bladder Tumor ; In Relation To Tissue Metallothionein Levels"J.Urol.. 170. 2467-2470 (2003)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Yukihiro Kondo, Seiichiro Himeno, Masahiko Satoh, Akira Naganuma, Taiji Nishimura, Nobumasa Imura: "Citrate enhances protective effect of orally administered bismuth subnitrate against nephrotoxicity of cis-diamminedichioroplatinum"Cancer Chem Pharmacol. 53. 33-38 (2004)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Maynard MA, Qi H, Chung J, Lee EHL, Kondo Y, Hara S, Conaway RC, Conaway JW, Ohh M: "Multiple splice variants of the human HIF-3 alpha locus are targets of the von Hippel-Lindau E3 ubiquitin ligase complex"J Biol Chem. 278(13). 11032-11040 (2003)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Yukihiro Kondo et al.: "Laparoscopic radical prostatectomy is possible to be standard therapy for early prostatic cancer."Int.J.Clin.Oncol.. 8(5). 312-316 (2003)

    • Related Report
      2003 Annual Research Report
  • [Publications] Yukihiro Kondo, et al.: "Optimal Administration Schedule Of Cisplatin For Bladder Tumor ; In Relation To Tissue Metallothionein Levels"J.Urol.. 170. 2467-2470 (2003)

    • Related Report
      2003 Annual Research Report
  • [Publications] Yukihiro Kondo et al.: "Citrate enhances protective effect of orally administered bismuth subnitrate against nephrotoxicity of cis-diamminedichloroplatinum"Cancer Chem Pharmacol. 53. 33-38 (2004)

    • Related Report
      2003 Annual Research Report

URL: 

Published: 2002-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi